Jubilant Ingrevia Limited (BOM:543271)

Market Cap	110.58B
Revenue (ttm)	42.15B
Net Income (ttm)	2.51B
Shares Out	n/a
EPS (ttm)	15.84
PE Ratio	44.03
Forward PE	33.47
Dividend	5.00 (0.72%)
Ex-Dividend Date	Feb 3, 2025

Volume	14,966
Average Volume	27,380
Open	652.65
Previous Close	680.00
Day's Range	652.65 - 703.45
52-Week Range	461.70 - 884.95
Beta	n/a
RSI	55.05
Earnings Date	May 13, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal...

• Industry: Chemicals and Allied Products
• Founded: 2019
• Employees: 2,283
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543271

Financial Performance

In 2024, Jubilant Ingrevia's revenue was 42.15 billion, an increase of 1.93% compared to the previous year's 41.36 billion. Earnings were 2.51 billion, an increase of 37.34%.